BackMilestone Pharmaceuticals Overview
Milestone Pharmaceuticals Inc

Milestone Pharmaceuticals Target Price

Analysts' average 12-month price target for Milestone Pharmaceuticals is $3.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.16

Average Target Price

$3.00158.6% upside

1 analysts in the last 4 months

High: $3 | Low: $3

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-20Cantor Fitzgerald$3158.6% upsideOpen
2026-04-10Raymond James$6417.2% upsideOpen
2025-12-16Wells FargoMohit Bansal$8589.7% upsideOpen
2025-12-15H.C. WainwrightBrandon Folkes$8589.7% upsideOpen
2022-04-22Piper Sandler$10762.1% upsideOpen

Milestone Pharmaceuticals (MIST) FAQ

As of the most recent data, MIST shows a target price of $3. Scroll down for historical charts and peer comparison views.

If Milestone Pharmaceuticals moved to the average analyst target of $3, shares would be roughly 158.6% higher than $1.16. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Milestone Pharmaceuticals's earnings trajectory.

Besides this target price page, Stockcircle has Milestone Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $3) with ownership activity and broader fundamentals.

Milestone Pharmaceuticals's target price is $3; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.